id: sud_medication_treatment_rate_oud_to_opioid_overdose_mortality
name: OUD Medication Treatment Rate â†’ Opioid Overdose Mortality
from_node:
  node_id: sud_medication_treatment_rate_oud
  node_name: OUD Medication Treatment Rate
to_node:
  node_id: opioid_overdose_mortality
  node_name: Opioid Overdose Mortality
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Opioid agonist treatment (OAT) provides pharmacological stabilization of opioid receptors'
- 'Step 2: Stabilization reduces cravings and withdrawal symptoms that drive continued opioid use'
- 'Step 3: Reduced illicit opioid use decreases exposure to fentanyl-contaminated supply'
- 'Step 4: Treatment retention allows for addressing co-occurring conditions and social determinants'
- 'Step 5: Sustained treatment engagement leads to reduced overdose risk and mortality'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Wendy P. Guastaferro et al. 2022. "Opioid Agonist Treatment Recipients within Criminal
    Justice-Involved Populations." https://doi.org/10.1080/10826084.2022.2034869
  supporting_citations:
  - Additional citations require full-text access - abstract references 'strong evidence that opioid agonist
    treatment (OAT) is effective in reducing overdose'
  - Additional citations require full-text access - abstract references evidence for 'increasing treatment
    retention'
  - Additional citations require full-text access - abstract references 'improving physical health and
    well-being outcomes'
  doi: 10.1080/10826084.2022.2034869
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: The paper references strong existing evidence that opioid agonist treatment is effective
  in reducing overdose deaths. This establishes the clinical pathway by which restricted access to OAT
  in criminal justice populations translates to preventable mortality. When justice-involved individuals
  are denied access to OAT, they face elevated overdose risk.
structural_competency:
  equity_implications: The well-established effectiveness of OAT in reducing overdose mortality makes
    the structural barrier created by the criminal justice system particularly egregious from an equity
    standpoint. Justice-involved populations, who already face elevated mortality risk upon release from
    incarceration, are systematically denied the most effective treatment available. This represents a
    structural determinant of health inequity that operates through policy and institutional arrangements
    rather than individual behavior.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.566228'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
